Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707895
What this trial is testing
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine Lung CarcinomaExtrapulmonary Neuroendocrine Carcinoma of Small Cell Histology+1 more
Boehringer Ingelheim 60